Dr. Stefan Glombitza at the Lupus Alpha Investment Focus 2024
Formycon CEO Dr. Stefan Glombitza spoke at the Lupus Alpha Investment Focus…
Biosimilars: efficative, safe cost-efficient.
Read how Formycon is making an important contribution to improve patient access…